Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Ticarcillin
Temocillin Disodium · icarcillin · TICARCILLIN · TRIARCILLIN · Ticarcillin acid · Ticcarcillin acid · Ticarcillin USP/EP/BP · Ticarcillin free base
식별자 및 물리적 특성
| CAS No. | 34787-01-4 |
|---|---|
| 분자식 | C15H16N2O6S2 |
| 평균 분자량 | 384.4 g/mol |
| 단동위원소 질량 | 384.04497858 g/mol |
| SMILES | CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](C(=O)O)c3ccsc3)C(=O)N2[C@H]1C(=O)O |
| InChIKey | OHKOGUYZJXTSFX-KZFFXBSXSA-N |
| PubChem CID | 36921 |
| ChEMBL | CHEMBL1449 |
| ChEBI | CHEBI:9587 |
| EC No. | 252-213-5 |
| DTXSID | DTXSID0023668 |
화학 및 물리적 성질
| XLogP | 0.8 |
|---|---|
| 극성 표면적 | 178 |
| 수소 결합 공여자 수 | 3 |
| 수소 결합 수용자 수 | 8 |
| 회전 가능 결합 수 | 5 |
| 무거운 원자 수 | 25 |
| 형식 전하 | 0 |
| 복잡도 | 640 |
| 의약품 | Pharmaceuticals -> AntibioticsPharmaceuticals -> Listed in ZINC15 |
| 용해도 | 7.16e-02 g/L |
| Human Drugs | Breast FeedingLactationMilk, HumanAnti-Infective AgentsAntibacterial AgentsPenicillins |
| Physical Description | Solid |
| 끓는 점 | 768.3±60.0 °C(Predicted) |
| 밀도 | 1.62±0.1 g/cm3(Predicted) |
| 저장 조건 | 2-8°C |
| pKa(산도 계수) | pKa 2.89±0.05(H2O t=25.0 I=0.15 (KCl)) (Uncertain)3.28±0.04 (Uncertain) |
안전 및 규제
| GHS 분류 | DangerH317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin]P233, P260, P261, P271, P272, P280, P284, P302+P352, P304+P340, P321, P333+P317, P342+P316, P362+P364, P403, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 40 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. |
|---|---|
| 기타 안전 정보 | IMAP assessments - 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[(carboxy-3-thienylacetyl)amino]-3,3-dimethyl-7-oxo-, [2S-[2.alpha.,5.alpha.,6.beta.(S*)]]-: Environment tier I assessment |
| Hazard Classes and Categories | Skin Sens. 1 (100%) |
| Hepatotoxicity | Intravenous ticarcillin therapy has been associated with mild and transient serum aminotransferase elevations that were generally self-limited and only slightly more common with ticarcillin than with comparative antibiotics. Much more commonly reported were instances of anicteric hepatic injury from carbenicillin, a similar carboxypenicillin with extend coverage against Pseudomonas. Persons receiving high doses of intravenous carbenicillin not uncommonly (15% to 30%) developed serum aminotransferase elevations without jaundice, which promptly fell to normal with discontinuation or switching to another antibiotic. Recurrence is common with retreatment using carbenicillin, but not with ticarcillin. A similar phenomenon occurs with intravenous oxacillin. Rare instances of idiosyncratic, clinically apparent cholestatic liver injury have been reported in persons receiving ticarcillin in combination with clavulanate, some of which resemble the rare idiosyncratic reactions that can occur with many penicillins and which resemble the cholestatic liver injury that occurs after amoxicillin/clavulanate. |
| Drug Induced Liver Injury | Drug-Induced Liver Injury Severity and Toxicity (DILIst)TicarcillinDILI NegativeIntramuscularIntravenousDOI:10.1016/j.drudis.2019.09.022 |
| Effects During Pregnancy and Lactation | ◉ Summary of Use during Lactation |
| 수질 위해 등급(WGK) | 3 |
| 위험 문구(R) |
용도
개요
Temocillin disodium is a broad-spectrum, β-lactamase resistant, injectable penicillin. High serum levels and a five hour half-life allow once or twice-daily dosing.